KLK3 and cancer: Several risk stratification systems, such as D'Amico risk groups and the Cancer of the Prostate Risk Assessment (CAPRA) score commonly use clinical T stage, serum prostate-specific antigen (PSA), and biopsy Gleason Score as risk assessment criteria4,34–36.